Detail Information of Transcriptional Regulations
General Information of Drug Transporter (DT) | |||||
---|---|---|---|---|---|
DT ID | DTD0254 Transporter Info | ||||
Gene Name | SLC2A12 | ||||
Transporter Name | Glucose transporter type 12 | ||||
Gene ID | |||||
UniProt ID | |||||
Transcriptional Regulation of This DT (TSR) | ||||||
---|---|---|---|---|---|---|
Class 1.1: Basic leucine zipper factors |
Click to Show/Hide the Full List of 6 TF(s) Regulating This DT |
|||||
ATF3 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Direct binding to SLC2A12 gene | [1] | ||||
TF Protein Name |
Cyclic AMP-dependent transcription factor ATF-3 | Transcription Factor Info | ||||
Tissue |
Colon | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Cyclic AMP-dependent transcription factor ATF-3 (ATF3) can directly bind to the SLC2A12 gene, which in turn affects the expression or function of the drug transporter Glucose transporter type 12. | |||||
CREB1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Direct binding to SLC2A12 gene | [2] | ||||
TF Protein Name |
Cyclic AMP-responsive element-binding protein 1 | Transcription Factor Info | ||||
Tissue |
Liver | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Cyclic AMP-responsive element-binding protein 1 (CREB1) can directly bind to the SLC2A12 gene, which in turn affects the expression or function of the drug transporter Glucose transporter type 12. | |||||
FOS |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Direct binding to SLC2A12 gene | [3] | ||||
TF Protein Name |
Protein c-Fos | Transcription Factor Info | ||||
Tissue |
Bone marrow; Breast; Vein | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Protein c-Fos (FOS) can directly bind to the SLC2A12 gene, which in turn affects the expression or function of the drug transporter Glucose transporter type 12. | |||||
FOSL1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Direct binding to SLC2A12 gene | [1] | ||||
TF Protein Name |
Fos-related antigen 1 | Transcription Factor Info | ||||
Tissue |
Bone marrow; Breast; Colon | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Fos-related antigen 1 (FOSL1) can directly bind to the SLC2A12 gene, which in turn affects the expression or function of the drug transporter Glucose transporter type 12. | |||||
FOSL2 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Direct binding to SLC2A12 gene | [4] | ||||
TF Protein Name |
Fos-related antigen 2 | Transcription Factor Info | ||||
Tissue |
Brain; Breast; Liver; Lung | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Fos-related antigen 2 (FOSL2) can directly bind to the SLC2A12 gene, which in turn affects the expression or function of the drug transporter Glucose transporter type 12. | |||||
JUND |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Direct binding to SLC2A12 gene | [2] | ||||
TF Protein Name |
Transcription factor JunD | Transcription Factor Info | ||||
Tissue |
Bone marrow; Brain; Cervix; Colon; Coronary artery; Embryo; Liver | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcription factor JunD (JUND) can directly bind to the SLC2A12 gene, which in turn affects the expression or function of the drug transporter Glucose transporter type 12. | |||||
Class 1.2: Basic helix-loop-helix factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
TWIST1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Activation of SLC2A12 gene in health condition | [5] | ||||
TF Protein Name |
Twist-related protein 1 | Transcription Factor Info | ||||
Affected Drug/Substrate |
Glucose | |||||
Studied Phenotype |
Heallth [ICD11: N.A] | |||||
Tissue |
Kidney | |||||
Related DT Changes |
Up regulating | |||||
Experimental Material |
Human kidney human embryonic kidney 293T cells (HEK 293T) | |||||
Detailed Description |
Twist-related protein 1 (TWIST1) has been reported to activate the transcription of SLC2A12 gene in health condition, which leads to an increased expression of the drug transporter Glucose transporter type 12. | |||||
Class 2.2: Other C4 zinc finger-type factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
GATA1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Direct binding to SLC2A12 gene | [4] | ||||
TF Protein Name |
Erythroid transcription factor | Transcription Factor Info | ||||
Tissue |
Blood; Bone marrow | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Erythroid transcription factor (GATA1) can directly bind to the SLC2A12 gene, which in turn affects the expression or function of the drug transporter Glucose transporter type 12. | |||||
Class 2.3: C2H2 zinc finger factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
MAZ |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Direct binding to SLC2A12 gene | [1] | ||||
TF Protein Name |
Myc-associated zinc finger protein | Transcription Factor Info | ||||
Tissue |
Lung | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Myc-associated zinc finger protein (MAZ) can directly bind to the SLC2A12 gene, which in turn affects the expression or function of the drug transporter Glucose transporter type 12. | |||||
Class 3.1: Homeo domain factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
NANOG |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Direct binding to SLC2A12 gene | [3] | ||||
TF Protein Name |
Homeobox protein NANOG | Transcription Factor Info | ||||
Tissue |
Embryo | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Homeobox protein NANOG (NANOG) can directly bind to the SLC2A12 gene, which in turn affects the expression or function of the drug transporter Glucose transporter type 12. | |||||
Class 3.3: Fork head / winged helix factors |
Click to Show/Hide the Full List of 4 TF(s) Regulating This DT |
|||||
FOXA1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Direct binding to SLC2A12 gene | [3] | ||||
TF Protein Name |
Hepatocyte nuclear factor 3-alpha | Transcription Factor Info | ||||
Tissue |
Breast; Embryo; Liver; Lung; Pancreatic ductal; Prostate | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Hepatocyte nuclear factor 3-alpha (FOXA1) can directly bind to the SLC2A12 gene, which in turn affects the expression or function of the drug transporter Glucose transporter type 12. | |||||
FOXA2 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Direct binding to SLC2A12 gene | [4] | ||||
TF Protein Name |
Hepatocyte nuclear factor 3-beta | Transcription Factor Info | ||||
Tissue |
Embryo; Endoderm; Liver; Lung; Skin | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Hepatocyte nuclear factor 3-beta (FOXA2) can directly bind to the SLC2A12 gene, which in turn affects the expression or function of the drug transporter Glucose transporter type 12. | |||||
FOXP1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Direct binding to SLC2A12 gene | [2] | ||||
TF Protein Name |
Forkhead box protein P1 | Transcription Factor Info | ||||
Tissue |
Prostate | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Forkhead box protein P1 (FOXP1) can directly bind to the SLC2A12 gene, which in turn affects the expression or function of the drug transporter Glucose transporter type 12. | |||||
RFX5 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Direct binding to SLC2A12 gene | [4] | ||||
TF Protein Name |
DNA-binding protein RFX5 | Transcription Factor Info | ||||
Tissue |
Brain; Cervix; Liver; Lung | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
DNA-binding protein RFX5 (RFX5) can directly bind to the SLC2A12 gene, which in turn affects the expression or function of the drug transporter Glucose transporter type 12. | |||||
Class 3.5: Tryptophan cluster factors |
Click to Show/Hide the Full List of 2 TF(s) Regulating This DT |
|||||
FLI1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Direct binding to SLC2A12 gene | [1] | ||||
TF Protein Name |
Friend leukemia integration 1 transcription factor | Transcription Factor Info | ||||
Tissue |
Blood; Mesenchymal; Vein | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Friend leukemia integration 1 transcription factor (FLI1) can directly bind to the SLC2A12 gene, which in turn affects the expression or function of the drug transporter Glucose transporter type 12. | |||||
SPI1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Direct binding to SLC2A12 gene | [1] | ||||
TF Protein Name |
Transcription factor PU.1 | Transcription Factor Info | ||||
Tissue |
Adrenal gland; Blood; Brain; Breast; Embryo; Foreskin; Heart; Intestine; Kidney; Lung; Muscle; Penis; Placenta; Renal cortex; Renal pelvis; Skin; Spinal cord; Stomach; Umbilical cord blood | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcription factor PU.1 (SPI1) can directly bind to the SLC2A12 gene, which in turn affects the expression or function of the drug transporter Glucose transporter type 12. | |||||
TF Superclass 4: Other all-alpha-helical DNA-binding domains |
||||||
Class 4.2: Heteromeric CCAAT-binding factors |
Click to Show/Hide the Full List of 2 TF(s) Regulating This DT |
|||||
NFYA |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Direct binding to SLC2A12 gene | [2] | ||||
TF Protein Name |
Nuclear transcription factor Y subunit alpha | Transcription Factor Info | ||||
Tissue |
Bone marrow | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Nuclear transcription factor Y subunit alpha (NFYA) can directly bind to the SLC2A12 gene, which in turn affects the expression or function of the drug transporter Glucose transporter type 12. | |||||
NFYB |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Direct binding to SLC2A12 gene | [3] | ||||
TF Protein Name |
Nuclear transcription factor Y subunit beta | Transcription Factor Info | ||||
Tissue |
Blood; Bone marrow; Cervix | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Nuclear transcription factor Y subunit beta (NFYB) can directly bind to the SLC2A12 gene, which in turn affects the expression or function of the drug transporter Glucose transporter type 12. | |||||
Class 6.3: p53 domain factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
TP53 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Repression of SLC2A12 gene in colon cancer condition | [6] | ||||
TF Protein Name |
Cellular tumor antigen p53 | Transcription Factor Info | ||||
Studied Phenotype |
Colon cancer [ICD11: 2B90] | |||||
Tissue |
Colon | |||||
Related DT Changes |
Down regulating | |||||
Experimental Material |
Human colon carcinoma cells (HCT-116) | |||||
Detailed Description |
Cellular tumor antigen p53 (TP53) has been reported to repress the transcription of SLC2A12 gene in colon cancer condition, which leads to a decreased expression of the drug transporter Glucose transporter type 12. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.